Every article, report, and earnings note where RXRX appears.
Keith Kohl of Angel Publishing’s Topline Trader is promoting “AI Doctor,” a pitch built around an AI drug-discovery biotech. The filings support the company match, but not several of the ad’s biggest claims.
GNQ Insilico is a TechBio precision-medicine company combining genomics, AI, and quantum computing, and it plans to go public by merging with IB Acquisition Corp. The deal is set up for a Q3 2026 close, but the real story is whether redemptions, dilution, and financing leave enough cash for the platform to execute.
These seven AI biotech stocks span diagnostics, software, platform discovery, and commercial therapeutics, ranked by investment quality for June 2026.
Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.
Generate RXRX ReportCancel anytime